How much funding has Zenas BioPharma raised?

Zenas BioPharma has raised $318.0M in total funding, most recently a Series C round.

Who are Zenas BioPharma's investors?

Zenas BioPharma's investors include SR One, Khosla Ventures, NEA, Shiv Chaudhary, Delos Capital, 5AM Ventures.

When was Zenas BioPharma founded?

Zenas BioPharma was founded in 2022.

Where is Zenas BioPharma headquartered?

Zenas BioPharma is headquartered in Boston, Massachusetts, United States.

What industry is Zenas BioPharma in?

Zenas BioPharma operates in Biotech, Healthcare, Life Sciences.

How many employees does Zenas BioPharma have?

Zenas BioPharma has 51-200 employees.

Zenas BioPharma

IPO

Enabling patients with autoimmune diseases to reimagine life.

Public · Boston, United States · Founded 2022 · $318.0M raised

Biotech

Healthcare

Life Sciences

Headquarters: Boston, Massachusetts
Employees: 51–200
Founded: 2022
Business Model: B2B
Website: zenasbio.com

Total Funding: $318.0M
Last Round: $200.0M Series CMay 2024
Rounds: 2
Type: Public

About

Zenas BioPharma is a clinical-stage global biopharmaceutical company focused on developing and commercializing transformative immunology-based therapies for autoimmune diseases with significant unmet patient needs. The company's proven leadership team advances a pipeline targeting conditions where current treatments remain inadequate. Zenas operates with a global development model, combining scientific rigor with commercial strategy.

Summary

Zenas BioPharma is a Biotech company based in Boston, United States, founded in 2022. It has raised $318.0M in total across 2 rounds, most recently a $200.0M Series C round in May 2024. Investors include SR One, Khosla Ventures and NEA.